Metapneumovirus

Pathogens-04-00682-g001

Metapneumovirus is a genus of viruses in the Pneumoviridae family, which is part of the order Mononegavirales. It is known to cause respiratory infections in humans, particularly in children, the elderly, and immunocompromised individuals. The most well-known virus in this genus is the Human metapneumovirus (hMPV), which was first identified in 2001. This virus is closely related to the Respiratory syncytial virus (RSV), another significant cause of respiratory illness.

Structure and Genome

Metapneumovirus has a non-segmented, negative-sense, single-stranded RNA genome. The virus is enveloped, meaning it has a lipid membrane derived from the host cell membrane. The genome encodes for several proteins, including the fusion (F) protein, attachment (G) protein, and the matrix (M) protein, which are critical for the virus's ability to infect host cells and initiate the replication process.

Transmission and Symptoms

Transmission of metapneumovirus occurs through respiratory droplets when an infected person coughs or sneezes. It can also be spread by direct contact with contaminated surfaces. The symptoms of a metapneumovirus infection are similar to other respiratory infections and can include cough, fever, nasal congestion, and in severe cases, bronchiolitis and pneumonia. The virus can cause acute respiratory tract infections and is a significant contributor to hospital admissions during the winter and spring months.

Diagnosis and Treatment

Diagnosis of metapneumovirus infection is typically based on the detection of viral RNA in respiratory specimens using reverse transcription polymerase chain reaction (RT-PCR). There is no specific antiviral treatment for metapneumovirus; management of the infection is supportive and focuses on relieving symptoms. This may include the use of antipyretics for fever, hydration, and in severe cases, hospitalization for supportive care including oxygen therapy.

Prevention

Preventive measures against metapneumovirus are similar to those for other respiratory viruses and include good hand hygiene, avoiding close contact with infected individuals, and covering coughs and sneezes with a tissue or the inside of the elbow. As of now, there is no vaccine available for metapneumovirus, but research is ongoing in the development of a vaccine to provide immunity against this virus.

Epidemiology

Since its discovery, metapneumovirus has been identified worldwide and is recognized as a significant cause of respiratory illness across all age groups, though it predominantly affects young children and the elderly. The virus circulates year-round but has a seasonal peak in the late winter and spring months in temperate climates.

Future Directions

Research on metapneumovirus continues to focus on understanding the virus's pathogenesis, improving diagnostic methods, and developing effective treatments and vaccines. Given its impact on public health, particularly among vulnerable populations, metapneumovirus remains an important area of study within the field of infectious diseases.

‎